Skip to main content

Market Overview

44 Stocks Moving In Tuesday's Mid-Day Session



  • Viveve Medical, Inc. (NASDAQ: VIVE) shares climbed 115.5% to $1.14 after the company announced positive primary efficacy data from its three-arm, five-month stress urinary incontinence feasibility study, which is comparing the company's cryogen-cooled monopolar radiofrequency treatment and a cryogen-only sham treatment to an inert sham treatment for mild-to-moderate SUI in women. Additionally, the company announced positive outcomes from an in-vivo preclinical study that was conducted to validate its new inert sham tip for use in the upcoming pivotal PURSUIT Trial in the U.S.
  • Sigma Labs, Inc. (NASDAQ: SGLB) gained 54.3% to $3.84 after the company reported that it has been awarded a contract by Mitsubishi Heavy Industries.
  • Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 28% to $7.08. On Monday, Orchard Therapeutics announced clinical data presentations at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation.
  • Jiayin Group Inc. (NASDAQ: JFIN) gained 26.3% to $3.41 amid US-China trade talks concerning the Phase 1 agreement.
  • Phoenix Tree Holdings Limited (NYSE: DNK) shares rose 24.6% to $7.91.
  • RISE Education Cayman Ltd (NASDAQ: REDU) surged 21.6% to $6.93. RISE Education Cayman, earlier during the month, reported results for the second quarter.
  • VivoPower International PLC (NASDAQ: VVPR) shares gained 18.5% to $3.90. VivoPower shares jumped 26% on Monday after the company reported better-than-expected preliminary results for FY20.
  • FTS International, Inc. (NYSE: FTSI) gained 18% to $3.7150. On Monday, FTS International reported an agreement with majority of its secured debtholders on restructuring support agreement to convert over $400 million of debt to equity.
  •, Inc. (NASDAQ: SPRT) climbed 15.5% to $2.335
  • Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) surged 15.2% to $2.3261. Idera Pharmaceuticals, earlier during the month, reported results for the second quarter.
  • Cutera, Inc. (NASDAQ: CUTR) gained 15% to $17.74. Cutera released Q2 results earlier in the month.
  • Wrap Technologies, Inc. (NASDAQ: WRTC) shares rose 15% to $8.94. Wrap Technologies, earlier during the month, said it received multiple international BolaWrap orders.
  • Greenland Technologies Holding Corporation (NASDAQ: GTEC) gained 14.3% to $3.2450.
  • iBio, Inc. (NASDAQ: IBIO) rose 13.8% to $2.5150 after jumping 30% on Monday.
  • Forte Biosciences, Inc. (NASDAQ: FBRX) surged 12.5% to $ 27.78 as the company reported inducement grants under Nasdaq listing rules.
  • Flotek Industries, Inc. (NYSE: FTK) shares climbed 12% to $2.41.
  • NIO Limited (NYSE: NIO) gained 12% to $ 16.77 after UBS upgraded the stock from Sell to Neutral.
  • Nano-X Imaging Ltd. (NASDAQ: NNOX) rose 9.6% to $29.25 after jumping 23% on Monday. Nano-X Imaging priced its IPO at $18 per share.
  • The Gap, Inc. (NYSE: GPS) gained 9% to $16.88 after Citigroup upgraded the stock from Neutral to Buy and raised the price target from $12 to $24.
  • J M Smucker Co (NYSE: SJM) gained 8.8% to $122.91 after the company reported upbeat Q1 results and raised its FY21 earnings guidance.
  • Ocugen, Inc. (NASDAQ: OCGN) shares gained 8% to $0.4425 after declining over 13% on Monday. Ocugen reported worse-than-expected Q2 earnings earlier during the month.
  • Immunovant Inc (NASDAQ: IMVT) gained 6.2% to $35.54 after the company announced the results from its multi-center, placebo-controlled Phase 2a trial of IMVT-1401 were statistically significant.
  • Amgen, Inc. (NASDAQ: AMGN) rose 4.8% to $246.76 after the stock was added to the Dow Jones Industrial Average on Monday.
  • Medtronic PLC (NYSE: MDT) gained 4.3% to $104.39 after reporting strong quarterly results.
  • Honeywell International Inc. (NYSE: HON) shares rose 3.6% to $165.07 after the stock was added to the Dow Jones Industrial Average on Monday.
  •, inc. (NYSE: CRM) rose 3.5% to $215.66 after the stock was added to the Dow Jones Industrial Average on Monday. The company is expected to release quarterly earnings after the closing bell today.


Check out these big penny stock gainers and losers


  • Northern Dynasty Minerals Ltd. (NYSE: NAK) fell 23% to $0.69. Northern Dynasty Minerals shares tumbled 38% on Monday following a Wall Street Journal report suggesting the company's gold and copper mine planned for Alaska faces a roadblock by the Trump administration over environmental concerns.
  • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) declined 21.8% to $3.05. Sonnet BioTherapeutics shares climbed over 48% on Monday after the U.S. FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • YRC Worldwide Inc. (NASDAQ: YRCW) fell 19% to $4.1250. Stifel reinstated YRC Worldwide with a Hold and announced a $5 price target.
  • NanoVibronix, Inc. (NASDAQ: NAOV) shares declined 18.6% to $0.7079 after the company reported a $2.5 million bought deal offering.
  • Cancer Genetics, Inc. (NASDAQ: CGIX) fell 16.9% to $5.20. Cancer Genetics shares jumped 115% on Monday after the company announced the entry into a definitive merger agreement with StemoniX.
  • Liminal BioSciences Inc. (NASDAQ: LMNL) shares declined 15% to $11.55. Liminal BioSciences gained 7% on Monday after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • The Children's Place, Inc. (NASDAQ: PLCE) shares dropped 14.3% to $19.97 after the company reported wider-than-expected Q2 loss.
  • Borqs Technologies, Inc. (NASDAQ: BRQS) fell 13% to $1.07. Borqs Technologies shares jumped around 40% on Monday after the company received a purchase order of over $15 million for mobile point-of-sale device in India.
  • Velocity Financial, Inc. (NYSE: VEL) shares declined 12.3% to $5.48 after gaining 19% on Monday. Velocity Financial, earlier during the month, released Q2 results.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) fell 12.1% to $0.3013. Onconova Therapeutics shares dipped 66% on Monday after the company’s Phase 3 INSPIRE trial did not meet its primary endpoint.
  • Riot Blockchain, Inc. (NASDAQ: RIOT) shares declined 11.4% to $3.2167. Riot Blockchain, last week, announced it has entered into an agreement with Bitmain Tech for the purchase of 8,000 Antminer S19 Digital Currency Miners for approximately $17.7 million.
  • EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) fell 11.4% to $0.54. On Monday, EyePoint Pharmaceuticals secured a new purchase and marketing agreement with Vantage Outsourcing for DEXYCU.
  • Dada Nexus Limited (NASDAQ: DADA) fell 11% to $26.65 after the company reported Q2 results and issued sales forecast for the third quarter.
  • Portland General Electric Company (NYSE: POR) fell 10.8% to $37.45 after the company lowered its FY20 earnings guidance, now expecting EPS of $1.30-$1.60, versus previous forecast of $2.20-$2.50.
  • NN, Inc. (NASDAQ: NNBR) fell 10.6% to $4.90. On Monday, NN reported the sale of life sciences division for $825 million.
  • Noah Holdings Limited (NYSE: NOAH) fell 7.7% to $27.93 after reporting quarterly earnings.
  • Smith & Wesson Brands, Inc. (NASDAQ: SWBI) shares gained 6.1% to $17.04. On Monday, Smith & Wesson Brands named Deana L. McPherson as CFO.
  • LM Funding America, Inc. (NASDAQ: LMFA) fell 5.5% to $0.6989. User-Friendly Phone Book disclosed a 21.5% active stake in the company.

Related Articles (AMGN + BRQS)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Penny Stocks Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at